Literature DB >> 20969858

Neferine inhibits cultured hepatic stellate cell activation and facilitates apoptosis: A possible molecular mechanism.

Hui Ding1, Jinghong Shi, Ying Wang, Jia Guo, Juhui Zhao, Lei Dong.   

Abstract

Neferine is a major alkaloid component of "Lian Zi Xin", embryos of the seeds of Nelumbo nucifera Gaertner, Nymphaeaceae. Previous studies have shown that neferine has an inhibitory effect on pulmonary fibrosis through its anti-inflammatory and anti-oxidative activities and inhibition of cytokines and NF-κB. However, it is unknown whether neferine also has an inhibitory effect on liver fibrosis through inhibition of TGF-β1 and collagen I and facilitation of apoptosis of hepatic stellate cells. This study examined the effects of neferine on cultured hepatic stellate (HSC-T6) cells and explored its possible action mechanisms by means of MTT assay, enzyme-linked immunosorbent assay, flow-cytometric annexin V-PI assay and Hoechst 33258 staining, as well as real-time PCR and western blotting. The results showed that neferine administration (2, 4, 6, 8 and 10μmol/l) significantly decreased the TGF-β1 and collagen I produced in HSC-T6 cells, and increased the HSC-T6 cell apoptosis in a dose-dependent manner. Neferine treatment for 48h at concentrations of 6 and 10μmol/l significantly increased Bax and caspase 3 mRNAs and proteins, and reduced Bcl2 and alpha-smooth muscle actin (α-SMA) mRNAs and proteins. Our data indicate that neferine efficiently inhibits cultured HSC-T6 cell activation and induces apoptosis by increasing Bax and caspase 3 expression via the mitochondrial pathway.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20969858     DOI: 10.1016/j.ejphar.2010.10.025

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Synergistic effect of hyperthermia and neferine on reverse multidrug resistance in adriamycin-resistant SGC7901/ADM gastric cancer cells.

Authors:  Chenghui Huang; Yaping Li; Peiguo Cao; Zhaoxia Xie; Zhiqiang Qin
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-08-07

2.  Identification and comparison of anti-inflammatory ingredients from different organs of Lotus nelumbo by UPLC/Q-TOF and PCA coupled with a NF-κB reporter gene assay.

Authors:  Mengge Zhou; Min Jiang; Xuhui Ying; Qingxin Cui; Yanqi Han; Yuanyuan Hou; Jie Gao; Gang Bai; Guoan Luo
Journal:  PLoS One       Date:  2013-11-29       Impact factor: 3.240

3.  Effect of medicated serum of Curcumae Radix extract on mRNA expression of TIMP-1, MMPs-13 and aI-collagen of HSC-T6 cell.

Authors:  Bo Shi; Jingjing Shi; Huazhen Qin
Journal:  Saudi Pharm J       Date:  2017-04-21       Impact factor: 4.330

4.  Regression of fibrosis by cilostazol in a rat model of thioacetamide-induced liver fibrosis: Up regulation of hepatic cAMP, and modulation of inflammatory, oxidative stress and apoptotic biomarkers.

Authors:  Sally A El Awdan; Rehab F Abdel Rahman; Heba M Ibrahim; Rehab R Hegazy; Salma A El Marasy; Manal Badawi; Mahmoud S Arbid
Journal:  PLoS One       Date:  2019-05-08       Impact factor: 3.240

5.  Moringa oleifera Alkaloids Inhibited PC3 Cells Growth and Migration Through the COX-2 Mediated Wnt/β-Catenin Signaling Pathway.

Authors:  Jing Xie; Feng-Xian Luo; Chong-Ying Shi; Wei-Wei Jiang; Ying-Yan Qian; Ming-Rong Yang; Shuang Song; Tian-Yi Dai; Lei Peng; Xiao-Yu Gao; Liang Tao; Yang Tian; Jun Sheng
Journal:  Front Pharmacol       Date:  2020-11-12       Impact factor: 5.810

6.  Demethyleneberberine Protects against Hepatic Fibrosis in Mice by Modulating NF-κB Signaling.

Authors:  Yongchen Wang; Zheng Zhao; Yan Yan; Xiaoyan Qiang; Cuisong Zhou; Ruiyan Li; Huan Chen; Yubin Zhang
Journal:  Int J Mol Sci       Date:  2016-06-30       Impact factor: 5.923

7.  MicroRNA-145 Increases the Apoptosis of Activated Hepatic Stellate Cells Induced by TRAIL through NF-κB Signaling Pathway.

Authors:  Junfa Yang; Qingxue Liu; Shiyang Cao; Tao Xu; Xiaofeng Li; Dandan Zhou; Linxin Pan; Changyao Li; Cheng Huang; Xiaoming Meng; Lei Zhang; Xiao Wang
Journal:  Front Pharmacol       Date:  2018-01-12       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.